Drawing for AFREZZAASSIST BY MANNKIND

USPTO serial 88929063

AFREZZAASSIST BY MANNKIND

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUKER, RACHEL EVE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AFREZZAASSIST BY MANNKIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jaclyne D. Wallace

Jaclyne D. Wallace Foley & Lardner LLP321 North Clark Street, Suite 3000Chicago, IL 60654UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036Providing a database featuring information about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; insurance consultation services, namely, assisting physician offices and patients to identify the scope of coverage offered by patient medical and pharmaceutical insurance; insurance benefits verification services in the medical field; insurance consultation services, namely, assisting physician offices and patients to obtain prior authorization for medical and pharmaceutical insurance claims and the preparation and submission of related paperwork and assisting physician offices and patients to appeal denial of medical and pharmaceutical insurance claims and the preparation and submission of related paperworkACTIVE—
042Providing temporary use of online non-downloadable software that assists patients with the filling and delivery of pharmaceutical prescriptions through communication with patient pharmaciesACTIVE—
044Medical information services, namely, providing a website in the medical, pharmaceutical and health fields featuring information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of diagnostics, patient treatment and treatment protocols; prescription reminder service for reminding patients of pharmaceutical preparation, dosage, allergic sensitivity, and refills for medical treatment purposes; medical services in the nature of providing medical advice in the field of pharmaceutical use, patient health and treatment services; medical services in the nature of providing information on health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility relating to therapy and the diagnostic, prophylactic and therapeutic properties of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 22, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 22, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2023EX5GSOU EXTENSION 5 GRANTED—
Jun 13, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 6, 2023EXT5SOU EXTENSION 5 FILED—
Jun 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 23, 2022EX4GSOU EXTENSION 4 GRANTED—
Nov 23, 2022EXT4SOU EXTENSION 4 FILED—
Nov 23, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 9, 2022EX3GSOU EXTENSION 3 GRANTED—
May 9, 2022EXT3SOU EXTENSION 3 FILED—
May 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2021EX2GSOU EXTENSION 2 GRANTED—
Dec 2, 2021EXT2SOU EXTENSION 2 FILED—
Dec 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2021EX1GSOU EXTENSION 1 GRANTED—
Jun 18, 2021EXT1SOU EXTENSION 1 FILED—
Jun 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 19, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 19, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 27, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2020DOCKASSIGNED TO EXAMINER—
Oct 7, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 10, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 8, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2020DOCKASSIGNED TO EXAMINER—
Jun 10, 2020MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 9, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 26, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance